Sign in

CIK 0001127537

  • Non-accelerated filer
  • Smaller reporting company

Pulmonx Corp

Sign in to watch
Ticker
LUNG
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 650-364-0400
Business address
700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Former names
PULMONX
  1. 4 Grant or award Director acquired 5,600 shares (grant or award)
  2. 4 Grant or award Director acquired 5,600 shares (grant or award)
  3. 4 Gift President and CEO gave 25,000 shares (gift)
  4. 4/A Insider Changes in Ownership
  5. 4 Exercise or conversion Chief Commercial Officer acquired 29,427 shares (option exercise)
  6. 4 Open-market sale Chief Financial Officer sold 458 shares at $25.91 ($11,867)
  7. 4 Open-market sale Chief Commercial Officer sold 426 shares at $25.91 ($11,038)
  8. 4 Open-market sale General Counsel sold 458 shares at $25.91 ($11,867)
  9. 4 Open-market sale President and CEO sold 1,132 shares at $25.91 ($29,330)
  10. 4 Open-market sale President and CEO sold 25,000 shares at an average $27.07 ($676,635)
  11. 4 Open-market sale President and CEO sold 25,000 shares at an average $25.11 ($627,696)
  12. 4 Open-market sale President and CEO sold 25,000 shares at an average $31.05 ($776,220)
  13. 4 Open-market sale Chief Commercial Officer sold 22,000 shares at an average $30.55 ($672,002)
  14. 4 Open-market sale Chief Financial Officer sold 6,000 shares at an average $31.71 ($190,255)
  15. 4 Open-market sale President and CEO sold 1,421 shares at $32.73 ($46,509)
  16. 4/A Open-market sale President and CEO sold 25,000 shares at an average $41.95 ($1,048,780)
  17. 4/A Open-market sale President and CEO sold 25,000 shares at an average $43.75 ($1,093,856)
  18. 4 Open-market sale General Counsel sold 383 shares at $32.73 ($12,536)
  19. 4 Open-market sale Chief Commercial Officer sold 355 shares at $32.73 ($11,619)
  20. 4 Open-market sale Chief Financial Officer sold 383 shares at $32.73 ($12,536)

Page 8 of 12 · 229 filings